ATLASATLAS fair value
$62.98
Close to fair value · 1% discount
Range: $57–$69Fair valuePrice
PTC Therapeutics (PTCT)
PTC Therapeutics stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$62.09▲ +1.67%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on PTC Therapeutics in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On PTC Therapeutics
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates PTC Therapeutics's fair value at about $62.98 per share (reasonable range: $56.68 to $69.27). At $62.09, the stock trades within 8% of that figure: close to fair value.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives PTC Therapeutics a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $57.65 and $66.66; in 9 out of 10, between $50.68 and $75.83. Estimated annual volatility is 38%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $5.4B
- 52-week high
- $90.87
- 52-week low
- $58.80
- Revenue (12 months)
- $1.0B
- Revenue growth (YoY)
- +114.5%
- Gross margin
- 97.3%
- Operating margin
- 49.5%
- Net margin
- 39.4%
- Return on equity
- -332.5%
- Free cash flow (12 months)
- $-287M
- Beta
- 0.55
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. PTC Therapeutics sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks PTCT has traded between $58.80 and $90.87. Today it is 31.7% below that high and 6% above its low.
On the business: revenue grew 114.5% year over year; net margin is 39.4%.
Its beta is 0.55: it tends to move less than the market.
About the company
PTC Therapeutics, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for people living with rare disorders.
Want to see everything about PTC Therapeutics?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is PTC Therapeutics (PTCT) fair value?
About $62.98 per share according to ATLAS (reasonable range: $56.68 to $69.27). With the stock at $62.09, it is close to that value.
What is the chance PTCT goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, PTCT ends the month between $57.65 and $66.66.
How big is PTC Therapeutics and what is its P/E ratio?
PTC Therapeutics's market capitalization is $5.4B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is PTCT?
ATLAS estimates annual volatility at 38%. In a typical month, half of the outcomes end between $57.65 and $66.66.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer